iBio

Sep 27, 2023

•

Jun 30, 2023

iBio Q4 2023 Earnings Report

iBio's financial performance for fiscal year 2023 was reported, with zero revenue and a net loss of $65.0 million.

Key Takeaways

iBio reported its fiscal year 2023 results, revealing no revenue and a consolidated net loss of $65.0 million. The company's operating expenses decreased by 7% compared to the previous year. iBio held $4.3 million in cash and cash equivalents as of June 30, 2023.

iBio reported zero revenue for the fiscal year 2023.

The company's consolidated net loss for fiscal year 2023 was $65.0 million.

Operating expenses decreased by 7% compared to the previous year.

iBio held $4.3 million in cash and cash equivalents as of June 30, 2023.